Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791

Inflammation and metabolic disorders

Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199

Toll-like receptor signalling

Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312

Extracellular vesicles: Exosomes, microvesicles, and friends

Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099

Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes

Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837

TLR4 links innate immunity and fatty acid-induced insulin resistance

Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416

A central role for JNK in obesity and insulin resistance

Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359

Vitamin A in Nonalcoholic Fatty Liver Disease: A Key Player in an Offside Position?

Berasain, C., & Avila, M. A. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.08.007 · Cited by 5

Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease

IGUDESMAN, D. A., Yu, G., Dauriat, C. J. G., Roman, T., Kashi, M. R., Blakley, E. A., Chassaing, B., & Corbin, K. D. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00381.2024 · Cited by 4

The COP9 Signalosome Variant CSNCSN7A Stabilizes the Deubiquitylating Enzyme CYLD Impeding Hepatic Steatosis

Huang, X., Dubiel, D., & Dubiel, W. (2021) · Livers · doi:10.3390/livers1030011 · Cited by 4

Non-alcoholic fatty liver disease - opportunities for personalized treatment and drug development

Kemas, A. M., Youhanna, S. C., & Lauschke, V. M. (2022) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2022.2053285 · Cited by 4

Influence of landscape ecology and physiological implications in bats from different trophic guilds

Torquetti, C. G., de Carvalho, T. P., de Freitas, R. M. P., Freitas, M. B., Guimarães, A. T. B., & Soto‐Blanco, B. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159631 · Cited by 5

Hepatocellular Carcinoma: Known and Emerging Risk Factors

Sciancalepore, D., Zingaro, M. T., Luglio, C. V., Sabbà, C., & Napoli, N. (2018) · Journal of Cancer Therapy · doi:10.4236/jct.2018.95037 · Cited by 4

High fat diet-induced downregulation of TRPV2 mediates hepatic steatosis via p21 signalling

Wei, P., Li, L., Ran, C., Jin, M., Zhao, H., Yang, K., Wang, Y., He, H., Jia, M., Pan, H., et al. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00988-8 · Cited by 3

The Role of Extracellular Vesicles in Mediating Signaling in Biliary Epithelial Cell Activation and Cholangiopathies

Fagoonee, S., Bolontrade, M. F., Defilippi, P., & Weiskirchen, R. (2025) · Cells · doi:10.3390/cells14161274 · Cited by 3

Investigating the process of apoptosis in HepG2 cells treated with palmitate, oleate, and palmitate/oleate combination

Torabi, S., Mohammadi, Y., Hoseini, M.-S., Rezaei, A., Mohammadi, A., & Bahreini, E. (2025) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2025.09.002 · Cited by 3

Trodusquemine (MSI-1436) Restores Metabolic Flexibility and Mitochondrial Dynamics in Insulin-Resistant Equine Hepatic Progenitor Cells (HPCs)

Qasem, B., Bourebaba, L., Dąbrowska, A., Króliczewski, J., Łyczko, J., & Marycz, K. (2024) · Cells · doi:10.3390/cells13020152 · Cited by 4

Deleted genes associated with obesity in Mexican patients diagnosed with nonalcoholic fatty liver disease

Zambrano‐Zaragoza, J. F., Vázquez‐Reyes, A., Durán‐Avelar, M. D. J., Gutiérrez‐Franco, J., Vibanco‐Pérez, N., Agraz‐Cibrián, J. M., Pérez‐Cambero, H., & Ayón‐Pérez, M. F. (2022) · Annals of Human Genetics · doi:10.1111/ahg.12466 · Cited by 3

Can Walnut Serve as a Magic Bullet for the Management of Non-Alcoholic Fatty Liver Disease?

Kim, M.-Y., & Choi, S. (2020) · Applied Sciences · doi:10.3390/app11010218 · Cited by 3

Ameliorating effects of melatonin on high-fat diet induced non-alcoholic fatty liver diseases and their associated pathologies: A comprehensive review

Ghosh, S., Khatoon, R., Sarkar, S., & Bandyopadhyay, D. (2023) · Melatonin Research · doi:10.32794/mr112500138 · Cited by 2

Regulation of Apoptosis by Bcl-2 Family Proteins in Liver Injury

Hikita, H., & Takehara, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-58106-4_5 · Cited by 3

Metabolic Risk Factors in Hepatocellular Carcinoma

Suceveanu, A., Mazilu, L., Gheorghe, A. D., Stoian, A. P., Voinea, F., & Suceveanu, A. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.80527 · Cited by 3

The mechanistic study of diacylglycerol in ameliorating non-alcoholic fatty liver and systemic lipid accumulation

Kang, D., Yang, Y., Zhang, Y., Zhang, J., He, Q., Luo, Z., Hong, A., Wang, Y., Liang, X., Chen, J., et al. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106373 · Cited by 4

CYP450 network shifts in MASLD/MASH: from pathogenesis to nutrition-informed modulation

Koç, S., Toydemir, S., Vardar, G., Öter, G. N., & Yusufoğlu, B. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110459 · Cited by 3

Management of non-alcoholic fatty liver disease in patients with sarcopenia

Hsu, C., & Kao, J. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1978978 · Cited by 2

To explore the pathogenesis and scientific connotation of non‐alcoholic fatty liver based on the theory of turbid toxin of traditional Chinese medicine

Kou, G., Luo, H., Huang, X., Bai, M., Cao, K., Ma, H., & Lv, X. (2024) · Advanced Chinese Medicine · doi:10.1002/acm4.1 · Cited by 3

Spatial and single-cell transcriptomics reveal the regional division of the spatial structure of NASH fibrosisPreprint

Li, M., Li, J., Ye, L.-H., Ni, L., Huang, X., Liang, X., Zhang, H.-C., Liu, Z., Zhang, X., Li, J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2958625/v1 · Cited by 2

Evaluation of efficacy, tolerability and safety of ademetionine in patients with non-alcoholic steatohepatitis with intrahepatic cholestasis syndrome. An open-label, comparative, multicenter, randomized, prospective trial HEPARD

Barna, O. М., & Korost, Y. V. (2023) · Modern Gastroenterology · doi:10.30978/mg-2023-4-41 · Cited by 1

Engineering Affibody Binders to Death Receptor 5 and Tumor Necrosis Factor Receptor 1 With Improved Stability

Nielsen, G. H., Sachs, J. N., & Hackel, B. J. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.28954 · Cited by 1

Effect of pemafibrate in reducing intestinal long-chain fatty acid absorption and hepatic fibrosis in metabolic dysfunction-associated steatohepatitis rats

Okada, M., Hanayama, M., Yamamoto, Y., Miyake, T., Yoshida, O., Takeshita, E., Ikeda, Y., & Hiasa, Y. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03967-z · Cited by 1

MASLD: Lipotoxicity and Imaging Parallels from Liver Steatosis to Kidney Injury

Săndulescu, S. M., Ghiga, D. Ș., Tudoraşcu, D. R., Săndulescu, L., Mită, A., Urhuț, M. C., & Taisescu, C. I. (2025) · Life · doi:10.3390/life15121805 · Cited by 3

Cold Stress Induces Tissue-Specific Lipid Metabolic Responses and Scd1-Mediated Hepatic Apoptosis in Silver Pomfret

Zhang, M., Zhang, L., Yuan, Z., Xu, S., Chen, Y., Xu, F., Qiu, Y., Tang, M., Dai, Q., Li, Y., et al. (2026) · Animals · doi:10.3390/ani16081196 · Cited by 1

High Remnant Cholesterol Increased the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) or Non-Alcoholic Fatty Liver Disease (NAFLD)

Biya, T., Sanusi, H. D., & Aman, A. M. (2026) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.041.01.5159 · Cited by 1

Metabolic dysfunction-associated fatty liver disease in chronic hepatitis B: dual effects on hepatocarcinogenesis and evolving strategies for risk prediction

Tao, H., Duan, Y., Yu, G., Yan, W., & Yin, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1817642 · Cited by 1

Therapeutic Mechanisms of Resmetirom and Semaglutide in MASLD/MASH: A Review of Inflammatory and Fibrotic Metabolites

Toshikuni, N. (2026) · Metabolites · doi:10.3390/metabo16080586 · Cited by 1

E4orf1 Prevents Progression of Fatty Liver Disease in Mice on High Fat Diet

Afruza, R., Dhurandhar, N. V., & Hegde, V. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169286 · Cited by 1

Epigenetics of NAFLD and NASH

DiStefano, J. K., & Wu, X. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823931-5.00006-2 · Cited by 1

Approaches to the Treatment of Lifestyle-related Diseases Through the Regulation of Phospholipid Biosynthesis in the Liver

Shimizu, K., Shindou, H., Tomita, K., & Nishinaka, T. (2025) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.24-00177-1 · Cited by 1

Apoptosis‐inducing factor deficient mice fail to develop hepatic steatosis under high fat high fructose diet or bile duct ligation

Sahu, P., Mohan, K. V., Aggarwal, S., Arindkar, S., Kumar, J. M., Upadhyay, P. K., Ramakrishna, G., & Nagarajan, P. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3579 · Cited by 1

Physiopathologie de la stéatose hépatique non-alcoolique (NAFLD)

Parlati, L., Régnier, M., Postic, C., & Guillou, H. (2023) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2023.03.005 · Cited by 1

Vinyl chloride enhances diet-induced liver injury via metabolic dyshomeostasis : critical role of mitochondria.

Lang, A. L. (2018) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2965 · Cited by 1

HFD-induced downregulation of TRPV2 mediates hepatic steatosis via p21 signalingPreprint

Wei, P., Li, L., Ran, C., Jin, M., Zhao, H., Yang, K., Wang, Y., Jia, M., Pan, H., Li, Q., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2215478/v1 · Cited by 1

Deletion of Endoplasmic Reticulum Stress Responsive Cochaperone P58IPK Protects Mice from Diet-Induced Steatohepatitis

Bandla, H., Nožičková, B., Mauer, A. S., & Malhi, H. (2017) · Gastroenterology · doi:10.1016/s0016-5085(17)33612-0

CORRECTION OF THE LIVER MORPHO-FUNCTIONAL STATE IN EXPERIMENTAL NON-ALCOHOLIC STEATHEPATITIS AND HYPERCHOLESTERINEMIA

Yakimenko, O. O., Appelhans, O. L., & Maznichenko, I. O. (2019) · World of Medicine and Biology · doi:10.26724/2079-8334-2019-3-69-239-244

Role of extracellular vesicles in hypoxia-induced hepatic injury in non-alcoholic fatty liver disease

Villanueva, A. H. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.180853744

Mechanisms of Fibrogenesis in NASH

Pastore, M., Gentilini, A., & Marra, F. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_6

The Effects of Western-diet, Palmitate, and TNFα on Hypothalamic Circadian Rhythms, NPY Expression, Neuroinflammation, and Cellular Insulin Sensitivity

Clemenzi, M. N. (2019) · TSpace (University of Toronto)

Nonalcoholic Fatty Liver Disease and Endoplasmic Reticulum Stress

Song, M. J. (2021) · Korean Journal of Medicine · doi:10.3904/kjm.2021.96.2.92

Chronic HBV Infection Associates with Improvement of Lipid Profile and Steatosis-Related Impairment in Nonalcoholic Fatty Liver Disease: A Lipidomic AnalysisPreprint

Li, H., Xu, Q.-Y., Xie, Y., Luo, J.-J., Cao, H., & Pan, Q. (2020) · Research Square · doi:10.21203/rs.3.rs-63441/v1

The Mechanism of Increased Intestinal Palmitic Acids Absorption and The Impact On Hepatic Stellate Cell Activation in Non-Alcoholic SteatohepatitisPreprint

Hanayama, M., Yamamoto, Y., Utsunomiya, H., Yoshida, O., Liu, S., Mogi, M., Matsuura, B., Takeshita, E., Ikeda, Y., & Hiasa, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-156446/v1

Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

Alvarado‐Tápias, E., Maya‐Miles, D., Albillos, A., Aller, R., Ampuero, J., Andrade, R. J., Arechederra, M., Aspichueta, P., Bañales, J. M., Blas‐García, A., et al. (2024) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2024.502207

Lack of Nr2e1 expression in hepatocytes impaired cell survival and aggravated palmitate-induced oxidative stress

Xiong, Q., Wang, H., Feng, J., Song, L., Wu, G., & Xu, Y. (2024) · Advances in Medical Sciences · doi:10.1016/j.advms.2024.06.002

Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

Alvarado‐Tápias, E., Maya‐Miles, D., Albillos, A., Aller, R., Ampuero, J., Andrade, R. J., Arechederra, M., Aspichueta, P., Bañales, J. M., Blas‐García, A., et al. (2024) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2024.502207

Advances in inflammaging in liver disease

Xu, Y., Chen, L., Liu, W., & Chen, L. (2025) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2024-0249 · Cited by 2

Potentiality of Stem Cell–Derived Extracellular Vesicles in the Setting of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)

Armandi, A., Caviglia, G. P., & Rosso, C. (2025) · Stem cells in clinical applications · doi:10.1007/978-3-031-90698-5_8

NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): DISEASE MECHANISMS AND CONTEMPORARY THERAPEUTIC APPROACHES - A LITERATURE REVIEW

Strużek, K., Kwiatkowska, A., Mączka, E., Tracz, W., Świercz, P., Teper, K., Khiralla-Gawlik, S., Strzelecka, A. A., & Basak, A. E. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3662

Bidirectional regulation of free fatty acid receptors and non-alcoholic fatty liver disease.

Lin, Y., Liu, Y., Liu, J., Wu, J., Wei, K.-H., Guo, J., & Su, Z.-Q. (2025) · Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110180

A consensus statement from the European Society for Clinical Investigation

Carbone, F., Després, J., Ioannidis, J. P. A., Neeland, I. J., Garruti, G., Busetto, L., Liberale, L., Ministrini, S., Vilahur, G., Schindler, T. H., et al. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Impact de la co-exposition au benzo[a]pyrène et à l'éthanol sur la progression pathologique de la stéatose hépatique

Tête, A. (2018) · theses.fr (ABES) · doi:10.70675/536d140cze42az4ee6zac88zf6315348b6fd

Mise en place et étude de modèles de progression de la NASH jusqu’au développement du CHC : effet du régime hyperlipidique sur l’environnement hépatique

Eugénio, M. S. (2019) · doi:10.70675/6b177437zf347z443bz8bb8z528243af0fa5

The roles of endoplasmic reticulum stress and Bax inhibitor-1 in non-alcoholic fatty liver disease

Lebeaupin, C. (2018) · theses.fr (ABES) · doi:10.70675/de500ab2z3c59z484dz8f58z7c3173626c42

Marqueurs diagnostiques et pronostiques de la stéatohépatite métabolique

Coilly, A. (2019) · theses.fr (ABES) · doi:10.70675/488abf31z3acfz4f13z88e2zd974ef8b9b7b

Diversité des macrophages dans un modèle murin de stéatohépatite non alcoolique

Tran, S. (2019) · theses.fr (ABES) · doi:10.70675/22efc884z2788z43fazabc1zaeb115ea6833

Contribution des cellules innées lymphoïdes de groupe 1 dans le développement de la stéatohépathie non alcoolique du foie

Vieira, É. (2020) · theses.fr (ABES) · doi:10.70675/a3d3dfefzd83dz4502zb987z5b0a8fe8cff5

Rôle de LECT2 dans les maladies stéatosiques non alcooliques du foie

Pham, S. (2020) · theses.fr (ABES) · doi:10.70675/3693bfe6z9d91z4045za9a9zc37497dc9c1b

Rôle de la kinase ATR dans la progression de la stéatose hépatique non alcoolique

Saroul-Aïnama, M. (2022) · theses.fr (ABES) · doi:10.70675/1fc5906az1637z451czab81z7529e034be63

Stéatopathie métabolique et carcinome hépatocellulaire : prédiction de la carcinogenèse à la réponse au traitement par profilage protéomique

Delamarre, A. (2024) · theses.fr (ABES) · doi:10.70675/ec8920bbza20cz485dzbc51zcc7223270689

Haizao Yuhu Decoction Inhibits Goiter via p53 Pathway‐Induced Apoptosis: Metabolomic and Cellular Assay Analysis

Liu, X., Liao, W., Xu, X., Wu, M., Zhang, J., Wu, Y., Chen, S., Liu, H., Zhang, S., Xiu, L., et al. (2026) · Biomedical Chromatography · doi:10.1002/bmc.70452

Multiparametric and Pathomimetic In Vitro Platform Mimicking Human Hepatic Steatosis, Lipotoxicity, and Associated Metabolic Stress

Sharma, J., & Dey, P. (2026) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6c00049

Prime editing enables isogenic modeling of PNPLA3-I148M-associated lipotoxicity in hepatocytes

Noguchi, H., Uchida, T., Wakita, N., Takenaga, M., Sakuma, T., Murakami, S., Inomata, M., Ono, A., Hagiwara, H., Hirashita, Y., et al. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102993

Nonlinear association of remnant cholesterol inflammatory index with metabolic dysfunction-associated steatotic liver disease in US adults: A cross-sectional NHANES study

Zhao, J., Xie, Z., Xu, X., & Zheng, Y. (2026) · Medicine · doi:10.1097/md.0000000000049741

Association of fat-related metabolic indices with MASLD and liver fibrosis: a cross-sectional analysis of NHANES 2017–2020

Shen, N., Wei, Q., Zhao, J., & Cai, J. (2026) · Medicine · doi:10.1097/md.0000000000049644

The role of lysine acylation in metabolic dysregulation and inflammatory responses within the hepatic immune microenvironment of MASLD

Peng, J., Yan, A., Chen, G., Gao, X., Yu, Q., Tian, W., & Cai, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1933792

Transcriptomic trajectory of hepatocyte ballooning reveals a lipotoxic point of no return and initiates oncogenic regulatory rewiring in MASLD

Ganguly, D., Mondal, B., Das, S., Dey, I., Mandal, A., Ghosh, T., Deo, M., Ahmed, M., Banerjee, S., Chatterjee, A., et al. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102785

The Role of the OSM/OSMRβ Axis in Chronic Liver Disease Progression and Hepatocellular Carcinoma Development: A Focus on MASLD/MASH

Foglia, B., Nurcis, J., Signorini, M., Novo, E., Bocca, C., Cannito, S., & Parola, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188213

Lipotoxicity in MAFLD/MASH: cellular mechanisms and targetable nodes

Tawai, J., Zhou, K., & Xiong, J. (2026) · Targetome · doi:10.48130/targetome-0026-0047

Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c‐Jun N‐terminal kinase‐1, and death receptors

Akazawa, Y., & Nakao, K. (2016) · Hepatology Research · doi:10.1111/hepr.12658 · Cited by 25

Pathogenic role of lipids in non-alcoholic fatty liver disease

Shulpekova, Y. O. (2012) · DOAJ (DOAJ: Directory of Open Access Journals)

Hepatocyte Lethal and Nonlethal Lipotoxic Injury

Hirsova, P., Ibrahim, S. H., Malhi, H., & Gores, G. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-53774-0_5 · Cited by 3

Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation

Ibrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278

Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis

Hirsova, P., & Gores, G. J. (2014) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.005 · Cited by 201